소아 심근염과 심근증 = The myocarditis and cardiomyopathy in children

다국어 초록 (Multilingual Abstract)

Myocarditis represent an important condition encountered by general pediatricians & general practitioners. Its presentation is varied, and therefore a high index of suspicion must be maintained when the possibility of myocarditis is raised. A progression from viral myocarditis to dilated cardiomyopathy has long been hypothesized. Treatment is initially aimed at achieving hemodynamic stability and is largely supportive. There is currently little evidence to support the immunomodulatory or specific antiviral therapies. Pediatric cardiomyopathies are a heterogeneous group of disorders with diverse genetic, infectious, mitochodrial and metabolic etiologies. The timing and severity of presentation vary according to cardiomyopathy type as well as genetic and ethnic factors. The behavior of specific cardiomyopathies can be predicted by morphological and functional attributes, as well as underlying patient characteristics.

참고문헌 (Reference)

1 Dec GW, "Viral myocarditis mimicking acute myocardial infarction" 20 : 85-89, 1992

2 Lipshultz SE, "The incidence of pediatric cardiomyopathy in two regions of the United States" 348 : 1647-1655, 2003

3 Nugent AW, "The epidemiology of childhood cardiomyopathy in Australia" 348 : 1639-1646, 2003

4 Cassling RS, "Quantitative evaluation of inflammation in biopsy specimens from idiopathically failing or irritable hearts: experience in 80 pediatric and adult patients" 110 : 713-720, 1985

5 Hofman P, "Prevalence of toxoplasma myocarditis in patients with the acquired immunodeficiency syndrome" 70 : 376-381, 1993

6 Weintraub RG, "Pediatric cardiomyopathy: The Australian experience" 23 : 17-24, 2007

7 Panhoweit S, "Parvovirus B19 genome in endomyocardial biopsy specimens" 109 : 179-, 2004

8 Magnani JW, "Myocarditis-current trends in diagnosis and treatment" 113 : 876-890, 2006

9 Sarda L, "Myocarditis in patients with clinical presentation of myocardial infarction and normal coronary angiograms" 37 : 786-792, 2001

10 Webb JG, "Myocarditis and myocardial hemorrhage associated with thrombotic thrombocytopenic purpura" 150 : 1535-1537, 1990

11 Feldman AM, "Myocarditis" 343 : 1388-1398, 2000

12 Pollick C, "Muscular subaortic stenosis: hemodynamic and clinical improvement after disopyramide" 307 : 997-999, 1982

13 Pulerwitz TC, "Mortality in primary and secondary myocarditis" 147 : 746-750, 2004

14 Baboonian C, "Meta-analysis of the association of enteroviruses with human heart disease" 78 : 539-543, 1997

15 Schulte HD, "Management of symptomatic hypertrophic obstructive cardiomyopathy-long-term results after surgical therapy" 47 : 213-218, 1999

16 Grogan M, "Long-term outcome of patients with biopsy-proved myocarditis: comparison with idiopathic dilated cardiomyopathy" 26 : 80-84, 1995

17 Grogan M, "Long-term outcome of patients with biopsy-proved myocarditis: comparison with idiopathic dilated cardiomyopathy" 26 : 80-84, 1995

18 McCarthy RE, "Long-term outcome of fulminant myocarditis as compared with acute (non-fulminant) myocarditis" 342 : 690-695, 2000

19 Miric M, "Long-term follow up of patients with dilated heart muscle disease treated with human leucocytic interferon alpha or thymic hormones: initial results" 75 : 596-601, 1996

20 Shanes JG, "Interobserver variability in the pathologic interpretation of endomyocardial biopsy results" 75 : 401-405, 1987

21 Towbin JA, "Incidence, cause, and outcomes of dilated cardiomyopathy in children" 296 : 1867-1876, 2006

22 Triska AE, "Improved outcomes of pediatric dilated cardiomyopathy with utilization of heart transplantation" 44 : 391-397, 2004

23 Wojnicz R, "Immunohistological diagnosis of myocarditis: potential role of sarcolemmal induction of the MHC and ICAM-1 in the detection of autoimmune mediated myocyte injury" 19 : 1564-1572, 1998

24 Kawai C, "From myocarditis to cardiomyopathy: mechanisms of inflammation and cell death: learning from the past for the future" 99 : 1091-1100, 1999

25 Mason JW, "For the Myocarditis Treatment Trial Investigators. A clinical trial of immunosuppressive therapy for myocarditis" 333 : 269-275, 1995

26 Cooper LT, "For the Multicenter Giant Cell Myocarditis Study Group Investigators. Idiopathic giant- cell myocarditis: natural history and treatment" 336 : 1860-1866, 1997

27 Arola A, "Epidemiology of idiopathic cardiomyopathies in children and adolescents: a nationwide study in Finland" 146 : 385-393, 1997

28 Bowles NE, "Detection of viruses in myocardial tissues by polymerase chain reaction: evidence of adenovirus as a common cause of myocarditis in children and adults" 42 : 466-472, 2003

29 Pauschinger M, "Detection of adenoviral genome in the myocardium of adult patients with idiopathic left ventricular dysfunction" 99 : 1348-1354, 1999

30 McNamara DM, "Controlled trial of intravenous immune globulin in recent-onset dilated cardiomyopathy" 103 : 2254-2259, 2001

31 Braunwald E, "Contemporary evaluation and management of hypertrophic cardiomyopathy" 106 : 1312-1316, 2002

32 Lieberman EB, "Clinicopathologic description of myocarditis" 18 : 1617-1626, 1991

33 Lieback E, "Clinical value of echocardiographic tissue characterization in the diagnosis of myocarditis" 17 : 135-142, 1996

34 Why HJ, "Clinical and prognostic significance of detection of enteroviral RNA in the myocardium of patients with myocarditis or dilated cardiomyopathy" 89 : 2582-2589, 1994

35 Doolan A, "Causes of sudden cardiac death in young Australians" 180 : 110-112, 2004

36 Dec GW, "Antimyosin antibody cardiac imaging: its role in the diagnosis of myocarditis" 16 : 97-104, 1990

37 Liu PP, "Advances in the understanding of myocarditis" 104 : 1076-1082, 2001

38 Dec GW, "Active myocarditis in the spectrum of acute dilated cardiomyopathies: clinical features, histologic correlates, and clinical outcome" 312 : 885-890, 1985

39 Hunt SA, "ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure)" 112 : 1825-1852, 2005

40 Parrillo JE, "A prospective, randomized, controlled trial of prednisone for dilated cardiomyopathy" 321 : 1061-1068, 1989